logo
#

Latest news with #BristolMyersSquibbCompany

Drug companies to pay Hawaii USD 700 million to settle Plavix blood thinner lawsuit
Drug companies to pay Hawaii USD 700 million to settle Plavix blood thinner lawsuit

Time of India

time10-05-2025

  • Business
  • Time of India

Drug companies to pay Hawaii USD 700 million to settle Plavix blood thinner lawsuit

Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel Pharmaceutical companies have agreed to pay Hawaii USD 700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office has announced. A court ruling last year ordered Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi to pay a combined USD 916 before an appeal was decided, a settlement was reached for the lower amount, the attorney general's office a joint statement on Friday, the companies said they "are pleased to resolve this litigation, and to continue their companies' focus on discovering, developing, and delivering innovative medicines to patients.""Plavix has helped millions of people with cardiovascular disease around the world for nearly 30 years and it continues to be endorsed as a first-line therapy by leading treatment guidelines across the globe," the statement Circuit Court Judge James Ashford found that there was a risk that about 30 per cent of patients, particularly non-Caucasians, might have a "diminished response" to Plavix but the companies did not update their labels, Attorney General Anne Lopez said last company has admitted Josh Green called it a "landmark settlement" and a "major victory" for the settlement divides the USD 700 million equally between Bristol Myers Squibb and Sanofi, with the funds to be paid by wire transfer by June 9, the attorney general's office said.

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

time10-05-2025

  • Business

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

HONOLULU -- Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office announced Friday. A court ruling last year ordered Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi to pay a combined $916 million. But before an appeal was decided, a settlement was reached for the lower amount, the attorney general's office said. In a joint statement, the companies said they 'are pleased to resolve this litigation, and to continue their companies' focus on discovering, developing, and delivering innovative medicines to patients.' 'Plavix has helped millions of people with cardiovascular disease around the world for nearly 30 years and it continues to be endorsed as a first-line therapy by leading treatment guidelines across the globe,' the statement added. First Circuit Court Judge James Ashford found that there was a risk that about 30% of patients, particularly non-Caucasians, might have a 'diminished response' to Plavix but the companies did not update their labels, Attorney General Anne Lopez said last year. Neither company has admitted wrongdoing. Gov. Josh Green called it a 'landmark settlement' and a 'major victory' for the state. The settlement divides the $700 million equally between Bristol Myers Squibb and Sanofi, with the funds to be paid by wire transfer by June 9, the attorney general's office said.

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit
Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

Yahoo

time10-05-2025

  • Business
  • Yahoo

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

HONOLULU (AP) — Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office announced Friday. A court ruling last year ordered Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi to pay a combined $916 million. But before an appeal was decided, a settlement was reached for the lower amount, the attorney general's office said. In a joint statement, the companies said they 'are pleased to resolve this litigation, and to continue their companies' focus on discovering, developing, and delivering innovative medicines to patients.' 'Plavix has helped millions of people with cardiovascular disease around the world for nearly 30 years and it continues to be endorsed as a first-line therapy by leading treatment guidelines across the globe,' the statement added. First Circuit Court Judge James Ashford found that there was a risk that about 30% of patients, particularly non-Caucasians, might have a 'diminished response' to Plavix but the companies did not update their labels, Attorney General Anne Lopez said last year. Neither company has admitted wrongdoing. Gov. Josh Green called it a 'landmark settlement' and a 'major victory' for the state. The settlement divides the $700 million equally between Bristol Myers Squibb and Sanofi, with the funds to be paid by wire transfer by June 9, the attorney general's office said.

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit
Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

Winnipeg Free Press

time10-05-2025

  • Business
  • Winnipeg Free Press

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

HONOLULU (AP) — Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office announced Friday. A court ruling last year ordered Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi to pay a combined $916 million. But before an appeal was decided, a settlement was reached for the lower amount, the attorney general's office said. A statement distributed by Sanofi said the companies 'are pleased to resolve this litigation, and to continue their companies' focus on discovering, developing, and delivering innovative medicines to patients.' 'Plavix has helped millions of people with cardiovascular disease around the world for nearly 30 years and it continues to be endorsed as a first-line therapy by leading treatment guidelines across the globe,' it added. First Circuit Court Judge James Ashford found that there was a risk that about 30% of patients, particularly non-Caucasians, might have a 'diminished response' to Plavix but the companies did not update their labels, Attorney General Anne Lopez said last year. Gov. Josh Green called it a 'landmark settlement' and a 'major victory' for the state. The settlement divides the $700 million equally between Bristol Myers Squibb and Sanofi, with the funds to be paid by wire transfer by June 9, the attorney general's office said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store